Literature DB >> 33708551

The usefulness of fluorodeoxyglucose-positron emission tomography as a preoperative diagnostic tool for thymic epithelial tumors.

Tsutomu Tatematsu1,2, Katsuhiro Okuda2, Yushi Saito1, Risa Oda2, Tadashi Sakane2, Keisuke Yokota2, Katsuhiko Endo2, Ryoichi Nakanishi2.   

Abstract

BACKGROUND: To investigate the usefulness of 18F-fluorodeoxy glucose-positron emission tomography (18F-FDG PET) for the preoperative imaging diagnosis of malignant grade in thymic epithelial tumors (TETs) and the correlation between the maximum standardized uptake value (SUVmax) and tumor size in TETs.
METHODS: We retrospectively investigated 51 patients with TETs performed 18F-FDG PET. The SUVmax was compared between thymic carcinomas and thymomas. We also evaluated the difference in the SUVmax limited to small TETs. In addition, the correlation between the SUVmax and the tumor size was evaluated.
RESULTS: The mean SUVmax of thymic carcinomas (n=12) and thymomas (n=39) was 5.71±2.6 and 3.08±1.4, respectively. The SUVmax of thymic carcinomas was significantly higher than that of thymomas (P<0.001). The mean SUVmax of these small thymic carcinomas (n=3) and thymomas (n=13) was 2.97±0.24 and 1.79±0.47, respectively. The SUVmax of the small thymic carcinomas was significantly higher than that of the thymomas (P=0.001). We found a positive correlation between the SUVmax and the maximum tumor size of TETs (correlation coefficient: 0.632, P<0.001).
CONCLUSIONS: 18F-FDG PET might be useful for evaluating the preoperative malignancy of TETs. Of note, the maximum tumor size should be considered when performing assessments by 18F-FDG PET. 2021 Gland Surgery. All rights reserved.

Entities:  

Keywords:  18F-fluorodeoxy glucose-positron emission tomography (18F-FDG PET); preoperative diagnosis; thymic carcinoma; thymic epithelial tumors (TETs)

Year:  2021        PMID: 33708551      PMCID: PMC7944073          DOI: 10.21037/gs-20-718

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  16 in total

1.  Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis.

Authors:  F Lococo; A Cesario; J Okami; G Cardillo; S Cavuto; T Tokunaga; G Apolone; S Margaritora; P Granone
Journal:  Lung Cancer       Date:  2013-08-13       Impact factor: 5.705

2.  18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups.

Authors:  Yon Mi Sung; Kyung Soo Lee; Byung-Tae Kim; Joon Young Choi; Young Mog Shim; Chin A Yi
Journal:  J Nucl Med       Date:  2006-10       Impact factor: 10.057

3.  Positron Emission Tomography in Thymic Tumors: Analysis Using a Prospective Research Database.

Authors:  Robert J Korst; Sumudinie Fernando; Ann Christine Catlin; John R Rutledge; Nicolas Girard; James Huang; Frank Detterbeck
Journal:  Ann Thorac Surg       Date:  2017-10-21       Impact factor: 4.330

4.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

5.  Fluorodeoxyglucose Positron Emission Tomography Can Provide Useful Information for Differentiating Thymic Epithelial Tumors.

Authors:  Masaki Tomita; Takanori Ayabe; Kazuyo Tsuchiya; Kunihide Nakamura
Journal:  Thorac Cardiovasc Surg       Date:  2017-07-20       Impact factor: 1.827

6.  Investigation of the freely available easy-to-use software 'EZR' for medical statistics.

Authors:  Y Kanda
Journal:  Bone Marrow Transplant       Date:  2012-12-03       Impact factor: 5.483

7.  Unilateral thoracoscopic subtotal thymectomy for the treatment of stage I and II thymoma.

Authors:  Makoto Odaka; Tadashi Akiba; Mitsuo Yabe; Miyako Hiramatsu; Hideki Matsudaira; Jun Hirano; Toshiaki Morikawa
Journal:  Eur J Cardiothorac Surg       Date:  2009-11-12       Impact factor: 4.191

8.  Value of 18F-FDG PET/CT for Predicting the World Health Organization Malignant Grade of Thymic Epithelial Tumors: Focused in Volume-Dependent Parameters.

Authors:  Seong Yong Park; Arthur Cho; Mi Kyung Bae; Chang Young Lee; Dae Joon Kim; Kyung Young Chung
Journal:  Clin Nucl Med       Date:  2016-01       Impact factor: 7.794

9.  Lung cancer screening: from imaging to biomarker.

Authors:  Dong Xiang; Bicheng Zhang; Donald Doll; Kui Shen; Goetz Kloecker; Carl Freter
Journal:  Biomark Res       Date:  2013-01-16

10.  Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo Metropolitan Cancer Center.

Authors:  Yusuke Okuma; Yukio Hosomi; Kageaki Watanabe; Yuko Yamada; Hirotoshi Horio; Yoshiharu Maeda; Tatsuru Okamura; Tsunekazu Hishima
Journal:  BMC Cancer       Date:  2014-05-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.